Sapna Gangaputra
Overview
Explore the profile of Sapna Gangaputra including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
65
Citations
1536
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cifuentes-Gonzalez C, Le Tong Y, Mejia-Salgado G, Chan R, Walter C, Rojas-Carabali W, et al.
Surv Ophthalmol
. 2025 Feb;
PMID: 39921003
This systematic review with meta-analysis explores the global demographic and etiological variations of retinal vasculitis (RV), focusing on differences in frequency, age, sex, and etiology across diverse geographic populations. RV...
2.
Panse K, Hang A, Ruiz J, Gangaputra S, Fan S, Fine J, et al.
Am J Ophthalmol
. 2024 Dec;
271:259-267.
PMID: 39645179
Purpose: To evaluate clinically relevant outcomes following suprachoroidal triamcinolone acetonide (TA) injection in eyes with noninfectious uveitis. Design: Retrospective interventional case series. Methods: Sixty-one eyes (51 patients) who underwent suprachoroidal...
3.
Fabiani C, Shantha J, Gangaputra S, Vitale A, Thorne J, Jabs D, et al.
Ocul Immunol Inflamm
. 2024 Nov;
:1-9.
PMID: 39535406
Purpose: The survey aims to explore the use of existing nomenclature and current clinical and multimodal imaging (MMI) approach in diagnosing white dot syndromes (WDS) among uveitis and retina specialists....
4.
Besagar S, de-la-Torre A, Thorne J, Biswas J, Agrawal R, Suhler E, et al.
Ocul Immunol Inflamm
. 2024 Oct;
:1-9.
PMID: 39360991
Intermediate uveitis is defined as inflammation of the vitreous and pars planitis. Etiology can be infectious, associated with a systemic disease, neoplastic or idiopathic. Pars planitis is the term used...
5.
Andrews H, Nair A, Hamdan S, Gangaputra S, Kim S
Am J Ophthalmol
. 2024 Aug;
246:251-257.
PMID: 39110158
Purpose: To evaluate the real-world therapeutic efficacy and safety of the novel, long-acting fluocinolone acetonide 0.18-mg injectable intravitreal implant (FAi) in chronic uveitis. Design: Retrospective case series. Methods: A retrospective...
6.
Rojas-Carabali W, Cifuentes-Gonzalez C, Gutierrez-Sinisterra L, Heng L, Tsui E, Gangaputra S, et al.
Asia Pac J Ophthalmol (Phila)
. 2024 Jul;
13(4):100082.
PMID: 39019261
The integration of artificial intelligence (AI) with healthcare has opened new avenues for diagnosing, treating, and managing medical conditions with remarkable precision. Uveitis, a diverse group of rare eye conditions...
7.
Hackstadt A, Elasy T, Gangaputra S, Harper K, Mayberry L, Nelson L, et al.
JMIR Res Protoc
. 2024 Jun;
13:e56123.
PMID: 38941148
Background: Despite the potential to significantly reduce complications, many patients do not consistently receive diabetes preventive care. Our research team recently applied user-centered design sprint methodology to develop a patient...
8.
Gangaputra S, Newcomb C, Ying G, Groth S, Fitzgerald T, Artornsombudh P, et al.
Am J Ophthalmol
. 2024 Jun;
267:182-191.
PMID: 38880375
Purpose: To evaluate the incidence, remission, and relapse of post-surgical cystoid macular edema (PCME) following cataract surgery in inflammatory eye disease. Methods: A total of 1859 eyes that had no...
9.
Levy-Clarke G, Newcomb C, Ying G, Groth S, Kothari S, Payal A, et al.
Can J Ophthalmol
. 2024 May;
60(1):e124-e132.
PMID: 38815957
Objective: To evaluate the incidence of visually significant posterior capsule opacification (PCO with visual acuity ≤20/50) and the incidence of Nd:YAG laser capsulotomy in the year following cataract surgery for...
10.
Jabs D, Sugar E, Burke A, Altaweel M, Dunn J, Gangaputra S, et al.
Am J Ophthalmol
. 2023 Jul;
254:210-220.
PMID: 37406846
Purpose: To evaluate the rate of, risk factors for, and outcomes of cataract surgery in patients with intermediate, posterior, and panuveitides treated with systemic corticosteroids and immunosuppression. Design: Cohort study...